Share
5-Aryl 1,3,4 -Thiadiazole Derivatives As Potential Anticancer Agents (in English)
Parin S. Sidat
(Author)
·
Malleshappa Noolvi
(Author)
·
Vishal G. Beldar
(Author)
·
LAP Lambert Academic Publishing
· Paperback
5-Aryl 1,3,4 -Thiadiazole Derivatives As Potential Anticancer Agents (in English) - Sidat, Parin S. ; Noolvi, Malleshappa ; Beldar, Vishal G.
$ 49.93
$ 59.29
You save: $ 9.36
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Tuesday, July 16 and
Wednesday, July 17.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "5-Aryl 1,3,4 -Thiadiazole Derivatives As Potential Anticancer Agents (in English)"
In search of new anticancer agents we have reported the synthesis of some 1,3,4-thiadiazoles. While designing target molecules, we studied some reported HDAC (Histone deacetylases) inhibitor and from that we have used some fragments to design new target molecules. The reaction was monitored by TLC using suitable mobile phase and also determined the melting point of the Thiadiazole analogues. It is found that they were different from each other's. Furthermore also characterized and confirmed by IR, 1H-NMR, and Mass spectral. For anticancer activity, all the selected compounds were submitted to NCI (National Cancer Institute) for in vitro anticancer activity. Primary in vitro one dose anticancer assay was performed in full NCI 60 cell panel in accordance with the protocol of the NCI, USA. The compound 5(a) and (6b) showed good activity against the all cancer cell lines at NCI, USA
